title: Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.
authors.affiliation: Epigenetics Group, International Agency for Research on Cancer, Lyon, France.
authors.forename: Hector
authors.initials: H
authors.lastname: Hernandez-Vargas
authors.forename: Marie-Pierre
authors.initials: MP
authors.lastname: Lambert
authors.forename: Florence
authors.initials: F
authors.lastname: Le Calvez-Kelm
authors.forename: Géraldine
authors.initials: G
authors.lastname: Gouysse
authors.forename: Sandrine
authors.initials: S
authors.lastname: McKay-Chopin
authors.forename: Sean V
authors.initials: SV
authors.lastname: Tavtigian
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
authors.forename: Zdenko
authors.initials: Z
authors.lastname: Herceg
mesh_terms: D000368:Aged; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000378:metabolism*; D016000:Cluster Analysis; D018899:CpG Islands; D019175:DNA Methylation; D044127:Epigenesis, Genetic; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008113:Liver Neoplasms / Q000235:genetics / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011401:Promoter Regions, Genetic; D012307:Risk Factors